天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

返回ChemicalBook首頁(yè)>CAS數(shù)據(jù)庫(kù)列表>1161002-05-6

1161002-05-6

中文名稱 G15;G-15;G 15;1161002-05-6
英文名稱 (3aS*,4R*,9bR*)-4-(6-Bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta[c]quinoline
CAS 1161002-05-6
分子式 C19H16BrNO2
分子量 370.24
MOL 文件 1161002-05-6.mol
更新日期 2023/03/20 15:41:25
1161002-05-6 結(jié)構(gòu)式 1161002-05-6 結(jié)構(gòu)式

基本信息

中文別名
15國(guó)集團(tuán)
化合物G15
(3AS,4R,9BR)-4-(6-溴苯并[D][1,3]二惡英-5-基)-3A,4,5,9B-四氫-3H-環(huán)戊烷[C]喹啉
英文別名
H37
G-15
RMB5
LUCA15
AGPAT1
1-AGPAT1
LPAAT-alpha
G15
G-15
G 15
1161002-05-6
RNA binding motif protein 5
Compound G15 - GPR30 antagonist

物理化學(xué)性質(zhì)

熔點(diǎn)178-180 °C
沸點(diǎn)462.7±45.0 °C(Predicted)
密度1.472±0.06 g/cm3(Predicted)
儲(chǔ)存條件-20°C儲(chǔ)存
溶解度insoluble in H2O; insoluble in EtOH; ≥37 mg/mL in DMSO
酸度系數(shù)(pKa)3.98±0.40(Predicted)
形態(tài)固體
顏色White to off-white

常見(jiàn)問(wèn)題列表

生物活性
G15是一種高親和力、選擇性的G-protein coupled estrogen receptor 1 (GPER, GPR30) 拮抗劑,約20 nM的結(jié)合親和力,在濃度高達(dá)10 μM時(shí),對(duì)ERα和ERβ沒(méi)有親和力。
靶點(diǎn)
TargetValue
GPER
()
體外研究

G15 (0.1-10 μM; 2 days) inhibits GPER-mediated proliferation stimulated by 17β-estradiol (E2) in A549 and H1793 cell lines.
G15 (1 μM; 48 hours) inhibits the response of GPER stimulated by E2 and G1 in A549 and H1793 cell lines.

Cell Proliferation Assay

Cell Line: A549, H1793 cell lines
Concentration: 0.1, 1, 10 μM (combination with 10 nM E2)
Incubation Time: 2 days
Result: Inhibited GPER-mediated proliferation stimulated by E2.

Western Blot Analysis

Cell Line: A549, H1793 cell lines
Concentration: 1 μM (combination with 10 nM E2 and 10 nM G1)
Incubation Time: 48 hours
Result: Inhibited the response of GPER stimulated by E2 and G1.
體內(nèi)研究

G15 (1.46 mg/kg; i.h.; twice a week for 14 weeks) decreases the number of tumor nodules and tumor index increased by the E2 or G1 group in urethane-induced adenocarcinoma mice.

Animal Model: Four-week-old female Kunming mice (Urethane-induced adenocarcinoma)
Dosage: 1.46 mg/kg (combination with E2, 0.09 mg/kg and fulvestrant (Ful), 2.4 mg/kg)
Administration: Subcutaneous injection; twice a week for 14 weeks
Result: The number of tumor nodules decreased in the E2+Ful+G15 group.
"1161002-05-6" 相關(guān)產(chǎn)品信息
16876-73-6 138-14-7 22260-51-1 115144-35-9 62253-63-8 16561-29-8 50-56-6 7440-22-4